Rosemont Pharmaceuticals
Huzaifah Patel is a Senior Formulation R&D Scientist at Rosemont Pharmaceuticals, a role held since January 2025. Prior experience includes serving as a Senior R&D Scientist at Jazz Pharmaceuticals from August 2023 to January 2025, and as a Senior Associate R&D Scientist at GW Pharmaceuticals plc from May 2019 to August 2023. Earlier in the career, Huzaifah worked in R&D Operations at RECKITT BENCKISER from July 2017 to May 2019. Huzaifah holds a Bachelor's degree in Chemistry from The Manchester Metropolitan University, obtained between 2014 and 2017, and completed A Levels in Chemistry at Heckmondwike Grammar School from 2012 to 2014.
This person is not in any teams
Rosemont Pharmaceuticals
At Rosemont our mission is to be a rapid developer, reliable manufacturer and global supplier of novel-delivery, patient-focused medicines. Our ambition has always been to support both patients with swallowing difficulties and the healthcare professionals who care for them. We are highly respected in the industry and have been instrumental in establishing best practice for the care of patients with swallowing difficulties. Rosemont advocate the use of liquid medication over manipulating solid dose medications and we have a range of educational materials designed for healthcare professionals which focuses on key patient groups and their medication management challenges. At Rosemont we have a portfolio of over 130 oral liquid medicines across a range of therapeutic areas including 70 licensed products. All of our products, both licensed and ‘specials’ are made to the same exacting standards under GMP. Our UK range also includes 9 products licensed for use with PEG/NG tubes. We are always seeking to expand our range of medicines and covert our ‘specials’ to licensed product wherever possible.